Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Halvard Bonig

Showing results (121-130 of 146) with videos related to

Pageof 15
Sort By:
Blood Advances|December 1, 2022
Retained functional normal and preleukemic HSCs at diagnosis are associated with good prognosis in DNMT3AmutNPM1mut AMLsElisa Donato, Nadia Correia, Carolin Andresen, et al.
Oncotarget|August 4, 2016
Bone marrow involvement identifies a subgroup of advanced Ewing sarcoma patients with fatal outcome irrespective of therapy in contrast to curable patients with multiple bone metastases but unaffected marrowUwe Thiel, Angela Wawer, Irene von Luettichau, et al.
Cells|December 9, 2023
Wnt/β-Catenin-Signaling Modulates Megakaryopoiesis at the Megakaryocyte-Erythrocyte Progenitor Stage in the Hematopoietic SystemBurak H Yalcin, Jadranka Macas, Eliza Wiercinska, et al.
Blood Advances|March 17, 2022
The differential role of the lipid raft-associated protein flotillin 2 for progression of myeloid leukemiaRahul Kumar, Raquel S Pereira, Julian Niemann, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 6, 2026
First-in-Human Study of IL15-Activated Cytokine-Induced Killer Cells After Allogeneic HCT Shows Durable Remission and Serotherapy-Associated Immune Reconstitution in LeukemiaEva Rettinger, Dirk Heckl, Martin Hutter, et al.
Blood|July 21, 2021
Siglec-6 is a novel target for CAR T-cell therapy in acute myeloid leukemiaHardikkumar Jetani, Almudena Navarro-Bailón, Marius Maucher, et al.
Oncoimmunology|January 3, 2024
Interferon regulatory factor 4 plays a pivotal role in the development of aGVHD-associated colitisJochen T Frueh, Julia Campe, Daniele Yumi Sunaga-Franze, et al.
Blood Advances|August 31, 2022
Impact of mesenchymal stromal cell-derived vesicular cargo on B-cell acute lymphoblastic leukemia progressionChristina Karantanou, Valentina R Minciacchi, Rahul Kumar, et al.
Blood|April 13, 2017
Continuous blockade of CXCR4 results in dramatic mobilization and expansion of hematopoietic stem and progenitor cellsDarja Karpova, Julie K Ritchey, Matthew S Holt, et al.
Cell Reports|May 16, 2019
Functional Dominance of CHIP-Mutated Hematopoietic Stem Cells in Patients Undergoing Autologous TransplantationChristina A Ortmann, Lena Dorsheimer, Khalil Abou-El-Ardat, et al.
Pageof 15

Showing results (121-130 of 146) with videos related to

Sort By:
Pageof 15
Blood Advances|December 1, 2022
Retained functional normal and preleukemic HSCs at diagnosis are associated with good prognosis in DNMT3AmutNPM1mut AMLsElisa Donato, Nadia Correia, Carolin Andresen, et al.
Oncotarget|August 4, 2016
Bone marrow involvement identifies a subgroup of advanced Ewing sarcoma patients with fatal outcome irrespective of therapy in contrast to curable patients with multiple bone metastases but unaffected marrowUwe Thiel, Angela Wawer, Irene von Luettichau, et al.
Cells|December 9, 2023
Wnt/β-Catenin-Signaling Modulates Megakaryopoiesis at the Megakaryocyte-Erythrocyte Progenitor Stage in the Hematopoietic SystemBurak H Yalcin, Jadranka Macas, Eliza Wiercinska, et al.
Blood Advances|March 17, 2022
The differential role of the lipid raft-associated protein flotillin 2 for progression of myeloid leukemiaRahul Kumar, Raquel S Pereira, Julian Niemann, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 6, 2026
First-in-Human Study of IL15-Activated Cytokine-Induced Killer Cells After Allogeneic HCT Shows Durable Remission and Serotherapy-Associated Immune Reconstitution in LeukemiaEva Rettinger, Dirk Heckl, Martin Hutter, et al.
Blood|July 21, 2021
Siglec-6 is a novel target for CAR T-cell therapy in acute myeloid leukemiaHardikkumar Jetani, Almudena Navarro-Bailón, Marius Maucher, et al.
Oncoimmunology|January 3, 2024
Interferon regulatory factor 4 plays a pivotal role in the development of aGVHD-associated colitisJochen T Frueh, Julia Campe, Daniele Yumi Sunaga-Franze, et al.
Blood Advances|August 31, 2022
Impact of mesenchymal stromal cell-derived vesicular cargo on B-cell acute lymphoblastic leukemia progressionChristina Karantanou, Valentina R Minciacchi, Rahul Kumar, et al.
Blood|April 13, 2017
Continuous blockade of CXCR4 results in dramatic mobilization and expansion of hematopoietic stem and progenitor cellsDarja Karpova, Julie K Ritchey, Matthew S Holt, et al.
Cell Reports|May 16, 2019
Functional Dominance of CHIP-Mutated Hematopoietic Stem Cells in Patients Undergoing Autologous TransplantationChristina A Ortmann, Lena Dorsheimer, Khalil Abou-El-Ardat, et al.
Pageof 15